How Is The Pharma Giant Expected To Perform Amid US Pressure?
Synopsis: Cipla is set to announce its Q4FY26 results on May 13, with brokerages expecting near-term pressure from US headwinds...
Pharma
Lantern Pharma Inc. (LTRN) Discusses LP-184 Phase 1a Clinical Results and Implications for DNA Damage Repair-Deficient Tumors Transcript
Panna SharmaPresident, CEO & Director Okay. Thank you, everyone, for joining us today for our LP-184 clinical trial results webinar....
Gilead, LEO Pharma partner to develop programs for inflammatory diseases By Reuters
(Reuters) - Gilead Sciences (NASDAQ:) said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop...
NVIDIA, Costco, Penguin Solutions, Avadel Pharma By Investing.com
After-hours movers: NVIDIA (NASDAQ:) fell 1.4% after Bloomberg reported that Biden will further curb AI chip exports in a final...
